Although serum from patients with lung cancer showed elevated levels of Cyfra21-1, NSE, CA125, CEA and SCC compared with the healthy group (Supplementary Table 1), our data showed that as single markers, MIC-1 was found to be elevated much earlier stage in the course of the disease and more progressively than any other five clinically available biomarkers. This evidence concerns the gene GDF15 and lung cancer.